Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine has created uncertainty across the vaccine industry, potentially affecting ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

CHICAGO, April 24 (Reuters) - Thousands of Americans campaigning for the Novavax (NVAX.O), opens new tab COVID-19 booster got some good news this week: the FDA signaled it might still win approval ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine ... to speak on behalf of the FDA. Novavax had anticipated ...

Federal regulators are asking Novavax NVAX-5.66%decrease; red down pointing triangle to complete an additional randomized clinical trial on its Covid-19 vaccine after previously delaying approval ...

Products that receive emergency authorization can be removed by FDA after there is no longer a health emergency. All the COVID-19 vaccines used in the U.S. train the body to fight the coronavirus ...

“The FDA has now endorsed treating COVID with Ivermectin!” the company tweeted, with no mention that its attached news clip was 20 months old or that it was incorrect. It added: “How many ...

But with FDA action, it would be the third vaccine against COVID-19 to receive full FDA approval, which could provide additional reassurance to people seeking the shot.The missed deadline came at ...

A person familiar with the situation told CNN that the FDA is seeking more data on the vaccine, which has been available under emergency use authorization since 2022. It was the first Covid-19 ...